These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


536 related items for PubMed ID: 18403709

  • 1. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models.
    Burdelya LG, Krivokrysenko VI, Tallant TC, Strom E, Gleiberman AS, Gupta D, Kurnasov OV, Fort FL, Osterman AL, Didonato JA, Feinstein E, Gudkov AV.
    Science; 2008 Apr 11; 320(5873):226-30. PubMed ID: 18403709
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Medicine. Drug bestows radiation resistance on mice and monkeys.
    Bhattacharjee Y.
    Science; 2008 Apr 11; 320(5873):163. PubMed ID: 18403680
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Harnessing the power of bacteria to protect the gut.
    Abreu MT.
    N Engl J Med; 2008 Aug 14; 359(7):756-9. PubMed ID: 18703481
    [No Abstract] [Full Text] [Related]

  • 7. Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation: implications for head-and-neck cancer radiotherapy.
    Burdelya LG, Gleiberman AS, Toshkov I, Aygun-Sunar S, Bapardekar M, Manderscheid-Kern P, Bellnier D, Krivokrysenko VI, Feinstein E, Gudkov AV.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):228-34. PubMed ID: 22000579
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. NLRC4 Mutation in flagellin-derived peptide CBLB502 ligand-binding domain reduces the inflammatory response but not radioprotective activity.
    Lai L, Yang G, Yao X, Wang L, Zhan Y, Yu M, Yin R, Li C, Yang X, Ge C.
    J Radiat Res; 2019 Nov 22; 60(6):780-785. PubMed ID: 31599956
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Toll-like receptor 5 agonism protects mice from radiation pneumonitis and pulmonary fibrosis.
    Wang ZD, Qiao YL, Tian XF, Zhang XQ, Zhou SX, Liu HX, Chen Y.
    Asian Pac J Cancer Prev; 2012 Nov 22; 13(9):4763-7. PubMed ID: 23167416
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CBLB502, an agonist of Toll-like receptor 5, has antioxidant and scavenging free radicals activities in vitro.
    Li W, Ge C, Yang L, Wang R, Lu Y, Gao Y, Li Z, Wu Y, Zheng X, Wang Z, Zhang C.
    Int J Biol Macromol; 2016 Jan 22; 82():97-103. PubMed ID: 26476243
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease.
    Ding X, Bian G, Leigh ND, Qiu J, McCarthy PL, Liu H, Aygun-Sunar S, Burdelya LG, Gudkov AV, Cao X.
    J Immunol; 2012 Nov 15; 189(10):4719-27. PubMed ID: 23045613
    [Abstract] [Full Text] [Related]

  • 19. Toll-like receptors and radiation protection.
    Liu Z, Lei X, Li X, Cai JM, Gao F, Yang YY.
    Eur Rev Med Pharmacol Sci; 2018 Jan 15; 22(1):31-39. PubMed ID: 29364499
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.